DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /EpigeneticsEpigenetics
  5. /Epigenetic Reader DomainEpigenetic Reader Domain
  6. /Ro-6870810Ro-6870810
Chemical structure of CAS 1349719-98-7

Ro-6870810

In Stock•Starting at $86 for 1 mg•Purity ≥ 98%
CAS No.1349719-98-7
MDL No.N/A
MFC27H34ClN7OS
MW540.10
InChI KeyPKQXLRYFPSZKDU-QFIPXVFZSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$86In Stock
5 mg98%$219In Stock
10 mg98%$346In Stock
25 mg98%$649In Stock
50 mg98%$1049In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1349719-98-7
Product NameRo-6870810
Heavy Atom Count37Rotatable Bond Count7
Atom Stereo Count1Bond Stereo Count0
HBA8HBD1
TPSA78.650 ŲCharge0
Exact Mass539.22341Complexity1305.00
pKa5.875XLogP3.943

Related Articles

Studies related to this compound and its mechanism of action

A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma.

British journal of cancer • Vol. 124, Issue 4 • 2021
PMID: 33311588PMC: PMC7884382DOI: 10.1038/s41416-020-01180-1

Documentation

Similar Products

  • N-[1-(2-chloroacetyl)piperidin-4-yl]-2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetamide

    CAS No.3065877-52-0

  • (+)-JQ-1-aldehyde

    CAS No.2634778-37-1

  • ET-JQ1-OH

    CAS No.2421153-77-5

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact